Apollo Hospitals achieved a new high, with shares surging over 6% to Rs 7,433.65, following impressive Q2 results. The healthcare giant exceeded expectations with significant growth in profit, revenue, and profitability, led by robust performance in all segments.
The company’s shares were trading at Rs 7,405 on the NSE at 09.19 am, reflecting investor enthusiasm for the stellar earnings reported for the July-September quarter. This market reaction underscores the strong financial health and investor confidence in Apollo Hospitals.
Also Read : Niva Bupa Health Insurance IPO Review
In Q2, Apollo Hospitals’ consolidated net profit soared by 59% to Rs 395.70 crore from Rs 248.80 crore in the same period last year. This increase is attributed to a 15% rise in revenue to Rs 5,589.3 crore, demonstrating the company’s robust operational performance.
Apollo HealthCo, Apollo Hospitals’ digital health and pharmacy vertical, turned a profit this quarter, reporting Rs 38.9 crore compared to a loss last year. This success has significantly contributed to the overall profitability and margin expansion for the company.
Check out our latest newsletter: US Trumped: But Will The Global Economy? What Trump’s Success Means for the Indian and Global Economy
The company’s EBITDA margin expanded sharply to 14.16% this quarter from 12.9% in the previous year, driven by improved occupancy rates in its flagship hospitals and enhanced performance across all segments. Occupancy rates rose to 73% from 68%, boosting patient inflow.
Apollo Hospitals is expanding its healthcare services by planning major projects, including a new 500-bed hospital in Mumbai and an expansion of its Lucknow facility from 300 to 500 beds. These initiatives are part of a broader strategy to add over 3,512 beds across India in four years.
Also Read : Waaree Energies Hits ₹1 Lakh Cr Market Cap with 40% Surge!
